Karolina Niska

Dr. Karolina Niska

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2018 in Chemico-Biological Interactions
Verified
Journal Article
Closed access
KNKarolina Niska
Karolina Niska
EZEwelina Zielinska
Ewelina Zielinska
MRMarek Witold Radomski
Marek Witold Radomski
IIIwona Inkielewicz-Stępniak
Iwona Inkielewicz-Stępniak

1 January 2016 in International Journal of Medical Sciences
Verified
Journal Article
Open access
KNKarolina Niska
Karolina Niska
Narcyz KnapNarcyz Knap
Narcyz Knap
AKAnna Kędzia
Anna Kędzia
MJMaciej Jaśkiewicz
Maciej Jaśkiewicz
Wojciech Kamysz, Pharm. D.Wojciech Kamysz, Pharm. D.
Wojciech Kamysz, Pharm. D.
IIIwona Inkielewicz-Stępniak
Iwona Inkielewicz-Stępniak
Objectives: In dentistry, silver nanoparticles (AgNPs) have drawn particular attention because of their wide antimicrobial activity spectrum. However, controversial information on AgNPs toxicity limited their use in oral infections. Therefore, the aim of the present study was to evaluate the antibacterial activities against a panel of oral pathogenic bacteria and bacterial biofilms together with potential cytotoxic effects on human gingival fibroblasts of 10 nm AgNPs: non-functionalized - uncapped (AgNPs-UC) as well as surface-functionalized with capping agent: lipoic acid (AgNPs-LA), polyethylene glycol (AgNPs-PEG) or tannic acid (AgNPs-TA) using silver nitrate (AgNO3) as control.

1 June 2015 in Toxicology in Vitro
Verified
Journal Article
Closed access
KNKarolina Niska
Karolina Niska
MSMaria Santos-Martinez
Maria Santos-Martinez
MRMarek Witold Radomski
Marek Witold Radomski
IIIwona Inkielewicz-Stępniak
Iwona Inkielewicz-Stępniak

1 February 2015 in International Journal of Nanomedicine
Verified
Journal Article
Open access
IIIwona Inkielewicz-Stepniak
Iwona Inkielewicz-Stepniak
KNKarolina Niska
Karolina Niska
KPKatarzyna Pyszka
Katarzyna Pyszka
CTCecylia Tukaj
Cecylia Tukaj
Michał WoźniakMichał Woźniak
Michał Woźniak
MRMarek Witold Radomski
Marek Witold Radomski
Titanium dioxide (TiO2) nanoparticles (NPs) are manufactured worldwide for a variety of engineering and bioengineering applications. TiO2NPs are frequently used as a material for orthopedic implants. However, to the best of our knowledge, the biocompatibility of TiO2NPs and their effects on osteoblast cells, which are responsible for the growth and remodeling of the human skeleton, have not been thoroughly investigated. In the research reported here, we studied the effects of exposing hFOB 1.19 human osteoblast cells to TiO2NPs (5–15 nm) for 24 and 48 hours. Cell viability, alkaline phosphatase (ALP) activity, cellular uptake of NPs, cell morphology, superoxide anion (O2•-) generation, superoxide dismutase (SOD) activity and protein level, sirtuin 3 (SIR3) protein level, correlation between manganese (Mn) SOD and SIR, total antioxidant capacity, and malondialdehyde were measured following exposure of hFOB 1.19 cells to TiO2NPs. Exposure of hFOB 1.19 cells to TiO2NPs resulted in: (1) cellular uptake of NPs; (2) increased cytotoxicity and cell death in a time- and concentration-dependent manner; (3) ultrastructure changes; (4) decreased SOD and ALP activity; (5) decreased protein levels of SOD1, SOD2, and SIR3; (6) decreased total antioxidant capacity; (7) increased O2•- generation; and (8) enhanced lipid peroxidation (malondialdehyde level). The linear relationship between the protein level of MnSOD and SIR3 and between O2•- content and SIR3 protein level was observed. Importantly, the cytotoxic effects of TiO2NPs were attenuated by the pretreatment of hFOB 1.19 cells with SOD, indicating the significant role of O2•- in the cell damage and death observed. Thus, decreased expression of SOD leading to increased oxidizing stress may underlie the nanotoxic effects of TiO2NPs on human osteoblasts.

18 February 2020 in Supramolecular Chemistry
Verified
Journal Article
Closed access
Elżbieta AdamskaElżbieta Adamska
Elżbieta Adamska
Aleksandra Bielicka-GiełdońAleksandra Bielicka-Giełdoń
Aleksandra Bielicka-Giełdoń
KNKarolina Niska
Karolina Niska
JSJustyna Strankowska
Justyna Strankowska
JŻJoanna Żebrowska
Joanna Żebrowska
BGBeata Grobelna
Beata Grobelna
The benefits of silver nanoparticles (AgNPs) have been known in many fields from catalysis through optics to medicine due to their unique size-dependent properties. Recently, there is also a growing interest in novel skincare formulations containing AgNPs. In this work, AgNPs were successfully synthesised and were characterised by UV-Vis spectroscopy and Transmission Electron Microscopy (TEM). In addition, an analysis of particle size distribution (measured by Dynamic Light Scattering – DLS) and zeta potential (using the method Electrophoretic Light Scattering – ELS) were made. The obtained AgNPs were in two sizes: small (20 nm ± 5 nm) and large (100 nm ± 5 nm). The assessment of the cytotoxic effect on human skin cells was done. Smaller AgNPs showed less cytotoxicity and thus greater safety for skin, so they were introduced into new skincare formulations such as oil/water (O/W) emulsion, water/oil (W/O) emulsion and hydrogel. Moreover, the study of release AgNPs from emulsions and hydrogel using Franz diffusion chamber with pig skin as a membrane has been conducted. The receptor fluid measurements were performed by Atomic Absorption Spectroscopy (AAS). The last point of the research was the performance of microbiological tests to determine the antibacterial effect of the smaller AgNPs in both solution and cosmetic. Graphical abstract

15 February 2017 in BioMetals
Verified
Journal Article
Open access
PDF file
ATAleksandra Tesmar
Aleksandra Tesmar
DWDariusz Wyrzykowski
Dariusz Wyrzykowski
RKRafal Kruszynski
Rafal Kruszynski
KNKarolina Niska
Karolina Niska
IIIwona Inkielewicz-Stępniak
Iwona Inkielewicz-Stępniak
LCLech Chmurzyński
Lech Chmurzyński
The use of protonated N-heterocyclic compound, i.e. 2,2′-bipyridinium cation, [bpyH+], enabled to obtain the new nitrilotriacetate oxidovanadium(IV) salt of the stoichiometry [bpyH][VO(nta)(H2O)]H2O. The X-ray measurements have revealed that the compound comprises the discrete mononuclear [VO(nta)(H2O)]− coordination ion that can be rarely found among other known compounds containing nitrilotriacetate oxidovanadium(IV) moieties. The antitumor activity of [bpyH][VO(nta)(H2O)]H2O and its phenanthroline analogue, [phenH][VO(nta)(H2O)](H2O)0.5, towards human osteosarcoma cell lines (MG-63 and HOS) has been assessed (the LDH and BrdU tests) and referred to cis-Pt(NH3)2Cl2 (used as a positive control). The compounds exert a stronger cytotoxic effect on MG-63 and HOS cells than in untransformed human osteoblast cell line. Thus, the [VO(nta)(H2O)]− containing coordination compounds can be considered as possible antitumor agents in the osteosarcoma model of bone-related cells in culture.